Want to see OHI full AI Analyst Report?
Top Page
Omega Healthcare
(NYSE:OHI)
Select Model
Select Model
Rating:74Outperform
Price Target:
$56.00
▲(8.28% Upside)
Action:Reiterated
Date:07/31/26
OHI’s score is driven primarily by improving fundamentals (revenue/profitability strength and better leverage) and a supportive earnings update (slightly raised/tightened FFO guidance plus meaningful liquidity improvement). Technicals add support via a clear uptrend versus key moving averages. The main offsets are the sharp recent free-cash-flow decline and a valuation profile that looks less compelling on P/E despite a strong dividend yield.
Positive Factors
Material deleveraging
Sustained reduction in leverage improves credit flexibility and lowers refinancing risk for a rate-sensitive REIT. A stronger balance sheet supports dividend coverage, enables accretive redeployment from asset sales, and increases resilience to operator stress over the next 2–6 months.
Negative Factors
Sharp FCF deceleration
A marked decline in free cash flow weakens near-term internal funding capacity and reduces margin for error on distributions or reinvestments. Even with healthy absolute cash levels, persistent FCF volatility could constrain redeployment timing and dividend flexibility over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Material deleveraging
Sustained reduction in leverage improves credit flexibility and lowers refinancing risk for a rate-sensitive REIT. A stronger balance sheet supports dividend coverage, enables accretive redeployment from asset sales, and increases resilience to operator stress over the next 2–6 months.
Read all positive factors
Omega Healthcare (OHI) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$15.34B
Dividend Yield5.31%
Average Volume (3M)1.96M
Price to Earnings (P/E)17.5
Beta (1Y)0.12
Revenue Growth15.18%
EPS Growth72.69%
CountryUS
Employees69
SectorReal Estate
Sector Strength53
IndustryREIT - Healthcare Facilities
Share Statistics
EPS (TTM)2.89
Shares Outstanding303,013,000
10 Day Avg. Volume1,832,185
30 Day Avg. Volume1,957,146
Financial Highlights & Ratios
PEG Ratio0.77
Price to Book (P/B)2.53
Price to Sales (P/S)10.96
P/FCF Ratio14.94
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$52.91Price Target Upside2.30% Upside
Rating ConsensusHold
Number of Analyst Covering12
EPS Forecast (FY)2.2
Revenue Forecast (FY)$1.08B
Omega Healthcare Business Overview & Revenue Model
Company Description
Omega Healthcare Investors, Inc. functions as a Real Estate Investment Trust (REIT) primarily focused on the long-term healthcare sector. The company strategically invests in properties providing skilled nursing and assisted living services. A div...
How the Company Makes Money
Omega Healthcare Investors makes money primarily by providing real estate capital to healthcare operators and earning contractual payments tied to that capital. The company’s key revenue streams are: (1) Rental income from long-term leases (often ...
Omega Healthcare Earnings Call Summary
Earnings Call Date:Jul 29, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Oct 29, 2026
Earnings Call Sentiment Positive
The call emphasized strong underlying fundamentals: year-over-year revenue and AFFO growth, significant liquidity and deleveraging, strategic asset sales executed at attractive economics, improved portfolio coverage, a robust investment pipeline (including first U.K. RIDEA), and a modestly tightened upward guidance. Near-term results are being muted by intentional strategic asset sales and loan repayments, and a small number of operator-specific issues (Genesis bankruptcy, Ciena transitions, localized occupancy gaps) and regulatory risks create some near-term uncertainty. Overall, management projects these actions will strengthen credit support and enable accretive redeployment in H2 2026 and 2027.Positive Updates
Revenue and Earnings Growth Year-over-Year
Q2 2026 revenue was $328M vs $283M in Q2 2025, a year-over-year increase of approximately 15.9%. Net income available to common shareholders was $363M ($1.19/share) vs $137M ($0.46/share) in Q2 2025 (net income per share increased ~158.7% YoY, primarily reflecting a $247M gain on asset sales).
Negative Updates
Near-Term Earnings Headwind from Asset Sales and Loan Repayments
Management noted significant asset dispositions ($563M–$597M referenced) and ~$209M in loan repayments over the past two quarters that muted sequential AFFO growth. Neal indicated the timing of late-quarter sales and repayments reduced Q2 AFFO by approximately $7.5M and created a temporary headwind expected to impact Q3 as well. Guidance includes roughly $9M of quarterly revenue impact associated with assets sold/loans repaid.
Read all updates
Q2-2026 Updates
Positive
Negative
Revenue and Earnings Growth Year-over-Year
Q2 2026 revenue was $328M vs $283M in Q2 2025, a year-over-year increase of approximately 15.9%. Net income available to common shareholders was $363M ($1.19/share) vs $137M ($0.46/share) in Q2 2025 (net income per share increased ~158.7% YoY, primarily reflecting a $247M gain on asset sales).
Read all positive updates
Company Guidance
Omega tightened and raised full‑year adjusted FFO guidance to $3.22–$3.26 per share (midpoint $3.24, up $0.02 from April), reflecting a near‑term headwind of about $9 million of quarterly revenue tied to assets sold and loans repaid late in Q2; the guidance includes new investments closed as of July 29 but excludes other transactions, assumes $56 million converts to fee simple of $144 million of mortgages/loans maturing in 2026 and that $180 million of non‑real‑estate loans (including ~ $148 million of Genesis loans) will be repaid in 2026, contemplates continued portfolio pruning of $15–$25 million of asset sales per quarter, incorporates the $0.01 common dividend increase, and notes the high end of the range could benefit from timing or extensions of repayments/sales, additional cash‑basis operator payments, RIDEA and JV operating exposure, and lower G&A.Omega Healthcare Financial Statement Overview
Summary
Income Statement
82
Very Positive
Balance Sheet
74
Positive
Cash Flow
69
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.29B | 1.20B | 1.05B | 949.74M | 878.24M | 1.06B |
| Gross Profit | 929.73M | 533.17M | 1.04B | 934.72M | 862.74M | 1.05B |
| EBITDA | 1.45B | 1.17B | 947.11M | 810.84M | 1.00B | 992.70M |
| Net Income | 858.31M | 590.11M | 406.33M | 242.18M | 426.93M | 416.74M |
Balance Sheet | ||||||
| Total Assets | 10.04B | 10.05B | 9.90B | 9.12B | 9.41B | 9.64B |
| Cash, Cash Equivalents and Short-Term Investments | 39.04M | 27.02M | 518.34M | 442.81M | 297.10M | 20.53M |
| Total Debt | 4.02B | 4.26B | 4.84B | 5.07B | 5.29B | 5.25B |
| Total Liabilities | 4.37B | 4.61B | 5.17B | 5.36B | 5.60B | 5.53B |
| Stockholders Equity | 5.39B | 5.18B | 4.54B | 3.57B | 3.61B | 3.91B |
Cash Flow | ||||||
| Free Cash Flow | 903.33M | 878.55M | 712.69M | 588.53M | 578.51M | 627.07M |
| Operating Cash Flow | 890.56M | 878.55M | 749.43M | 626.54M | 625.73M | 722.14M |
| Investing Cash Flow | 186.54M | -539.79M | -671.16M | -9.78M | 442.85M | -524.17M |
| Financing Cash Flow | -1.66B | -838.26M | 26.32M | -473.31M | -789.45M | -341.12M |
Omega Healthcare Technical Analysis
Neutral
51.72
Price Trends
47.28
Positive
46.29
Positive
44.64
Positive
Market Momentum
0.36
Positive
47.13
Neutral
20.59
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For OHI, the sentiment is Neutral. The current price of 51.72 is above the 20-day moving average (MA) of 49.36, above the 50-day MA of 47.28, and above the 200-day MA of 44.64, indicating a neutral trend. The MACD of 0.36 indicates Positive momentum. The RSI at 47.13 is Neutral, neither overbought nor oversold. The STOCH value of 20.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for OHI.
Omega Healthcare Risk Analysis
Omega Healthcare disclosed 74 risk factors in its most recent earnings report. Omega Healthcare reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Omega Healthcare Peers Comparison
UnderperformOutperform
Sector (65)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $9.91B | 26.71 | 8.54% | 3.35% | 58.48% | 70.32% | |
74 Outperform | $15.34B | 17.52 | 16.51% | 5.18% | 15.18% | 72.69% | |
66 Neutral | $11.60B | 95.47 | 5.87% | 1.74% | 12.24% | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | $5.34B | 32.87 | 2.31% | 5.37% | 13.50% | 7.25% | |
63 Neutral | $7.20B | -80.10 | -1.94% | 4.49% | -6.44% | 46.41% | |
62 Neutral | $15.42B | 69.21 | 3.30% | 5.48% | 2.71% | -19.70% |
* Real Estate Sector Average
OHI
Omega Healthcare
48.46
10.57
27.89%
DOC
Healthpeak Properties
21.41
5.74
36.60%
SBRA
Sabra Healthcare REIT
21.04
3.52
20.07%
HR
Healthcare Realty Trust
19.97
4.10
25.85%
CTRE
CareTrust REIT
41.22
9.62
30.43%
AHR
American Healthcare REIT, Inc.
56.74
17.22
43.56%
Omega Healthcare Corporate Events
Executive/Board ChangesRegulatory Filings and ComplianceShareholder Meetings
Omega Healthcare Shareholders Approve Directors and Compensation
Positive
Jun 5, 2026
On June 5, 2026, Omega Healthcare Investors, Inc. held its 2026 annual meeting of stockholders, where all director nominees were elected, Ernst Young LLP was ratified as independent auditor for 2026, and the company’s executive compensation...
Business Operations and StrategyExecutive/Board Changes
Omega Healthcare unveils leadership succession and governance transition
Positive
May 21, 2026
Omega Healthcare Investors, Inc., a REIT investing in long-term healthcare real estate such as skilled nursing and assisted living facilities in the U.S. and U.K., relies on a predominantly triple-net lease model with a diverse operator base. The ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.